
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. At Evolus, you have the opportunity to be part of a movement. A performance beauty company changing the game. We are bringing innovation and forward-thinking technology to an industry desperately wanting frictionless experiences. Our work disrupts the status quo, but most importantly, we will make an impact, we are customer-centric - always. Because of this, we are excited to step through the door each morning. We help each other climb; we don't climb over one another. We believe that integrity and a team-driven environment connect entrepreneurial minds. Getting goose bumps? Good. Join the Evolus movement, and let's see where you can put your talents to work.
Unlock the market timeline & signal feed
8 signals in the last 90 days.
The order this company entered each market — oldest to newest
Medical Affairs Clinician - Italy
International Supply Chain Manager
Sign up to see the full signal feed
How Evolus's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
EvolusYou | 7 | 5 | -86% | 8 | 25 |
Professional Education Manager INTL
View postingMilan, Lombardy, Italy · last wk.
International Marketing Specialist
View postingMilan, Lombardy, Italy · last wk.
Aesthetic Experience Manager – Hawaii
View postingHonolulu, HI · 3w ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Telix Pharmaceuticals appoints David Gill as Non-Executive Director effective May 11, 2026, with plans for him to become Chair. Gill brings 35+ years of life sciences experience.
Telix Pharmaceuticals appoints David Gill as Non-Executive Director effective May 11, 2026, as part of board expansion. Gill will eventually succeed Dr. Mark Nelson as Chair.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Evolus's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.